Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $81
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson maintains a 'Buy' rating on Merit Medical Systems (NASDAQ:MMSI) but lowers the price target from $96 to $81.
October 27, 2023 | 10:59 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham analyst maintains a 'Buy' rating on Merit Medical Systems but lowers the price target from $96 to $81.
The news is directly related to Merit Medical Systems. While the 'Buy' rating is maintained, the lowering of the price target might create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100